Psychiatry · Richmond, VA
NPI
1134285927
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7329 Boulder View Ln
Richmond, VA, 23225
Phone (804) 320-8570
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
4,942 prescriptions
Company payments, 2024
$454
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paul M Spector prescribed most often to Medicare patients was Clonazepam, with 277 prescriptions and refills. In total Paul M Spector wrote 4,942 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 277 | 343 | 42 | $2,878 |
| Gabapentin Generic | 181 | 227 | 36 | $4,172 |
| Oxycodone Hcl Generic | 156 | 156 | 22 | $4,420 |
| Vilazodone Hcl Generic | 143 | 198 | 26 | $12K |
| Escitalopram Oxalate Generic | 114 | 211 | 24 | $1,272 |
| Bupropion Xl Bupropion Hcl | 113 | 207 | 25 | $2,032 |
| Diazepam Generic | 107 | 121 | 16 | $699 |
| Duloxetine Hcl Generic | 105 | 155 | 16 | $1,269 |
| Morphine Sulfate Er Morphine Sulfate | 99 | 99 | 17 | $5,396 |
| Alprazolam Generic | 97 | 102 | 16 | $697 |
| Lorazepam Generic | 89 | 114 | 20 | $765 |
| Pregabalin Generic | 88 | 114 | 16 | $2,840 |
| Eszopiclone Generic | 84 | 116 | 17 | $961 |
| Methylphenidate Hcl Generic | 81 | 99 | 18 | $1,695 |
| Lamotrigine Generic | 79 | 142 | 13 | $1,353 |
Brand drugs: 570 claims; generic drugs: 4,372 claims; opioid claims: 669.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Paul M Spector $454 ($454 in general payments such as food, travel and fees) from 3 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $303.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.